Doxycyklin EQL Pharma
Doxycycline monohydrate 100 mg – Tetracycline antibiotic for bacterial infections
Quick facts about Doxycyklin EQL Pharma
Key takeaways about Doxycyklin EQL Pharma
- Broad-spectrum antibiotic: Effective against pneumonia, chlamydia, Lyme disease (borreliosis), chronic bronchitis exacerbations, and sinusitis
- Sun sensitivity: Avoid sun exposure and tanning beds during treatment and for at least 5 days after completion to prevent photosensitivity reactions
- Take with food: Always take tablets with food and a full glass of water, and remain upright afterwards to prevent esophageal irritation
- Not for young children: Generally not recommended for children under 8 years due to risk of permanent tooth discoloration and effects on developing bones
- Complete the full course: Even if symptoms improve after a few days, always finish the entire prescribed course to prevent bacterial resistance and infection recurrence
What Is Doxycyklin EQL Pharma and What Is It Used For?
Doxycyklin EQL Pharma is a tetracycline antibiotic that contains doxycycline monohydrate (100 mg). It works by inhibiting bacterial protein synthesis, effectively stopping bacteria from growing and multiplying. It is prescribed for pneumonia, acute bronchitis exacerbations, chlamydia infections, Lyme disease, and sinusitis.
Doxycycline belongs to the tetracycline class of antibiotics, one of the oldest and most widely used groups of antimicrobial agents in clinical medicine. First developed in the 1960s, doxycycline has remained a cornerstone antibiotic due to its broad-spectrum activity, excellent oral bioavailability, and favorable pharmacokinetic profile. Unlike many other antibiotics, doxycycline is absorbed almost completely from the gastrointestinal tract, with a bioavailability of approximately 90–100%, even when taken with food.
The mechanism of action of doxycycline is bacteriostatic, meaning it prevents bacteria from multiplying rather than directly killing them. It achieves this by binding reversibly to the 30S ribosomal subunit of bacterial ribosomes, blocking the attachment of aminoacyl-transfer RNA (tRNA) to the messenger RNA (mRNA)–ribosome complex. This effectively halts bacterial protein synthesis, preventing the bacteria from producing the proteins necessary for their growth and reproduction. The body’s own immune system can then eliminate the weakened bacteria.
Doxycyklin EQL Pharma is licensed for the treatment of several important infections. Pneumonia (community-acquired pneumonia caused by susceptible organisms) is a primary indication, as doxycycline covers many of the common respiratory pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and atypical organisms such as Mycoplasma pneumoniae and Chlamydophila pneumoniae. It is also used for acute exacerbations of chronic bronchitis, providing effective coverage against the bacteria most commonly responsible for these flare-ups.
Chlamydia infections of the urinary and genital tract represent another important indication. Doxycycline 100 mg twice daily for 7 days is the recommended first-line treatment for uncomplicated genital chlamydia according to guidelines from both the World Health Organization (WHO) and the European guideline on the management of chlamydia. It is also effective against other sexually transmitted infections such as non-gonococcal urethritis.
Lyme disease (borreliosis) caused by Borrelia burgdorferi transmitted through tick bites is another key indication. Doxycycline is the first-line treatment for early localized Lyme disease (erythema migrans) in adults and children over 8 years, typically prescribed for 10–21 days depending on clinical guidelines. It is the only oral antibiotic effective against Lyme disease that also provides coverage against the co-infection Anaplasma phagocytophilum.
Additionally, Doxycyklin EQL Pharma is indicated for acute sinusitis in patients who are allergic to penicillins or when penicillin-based treatment has not produced the desired therapeutic effect. This makes it a valuable second-line option for patients with penicillin hypersensitivity.
Antibiotics like doxycycline only work against bacterial infections. They are not effective against viral infections such as the common cold or influenza. Inappropriate use of antibiotics contributes to antimicrobial resistance, which is recognized by the WHO as one of the greatest threats to global health. Always take antibiotics exactly as prescribed by your healthcare provider.
What Should You Know Before Taking Doxycyklin EQL Pharma?
Do not take Doxycyklin EQL Pharma if you are allergic to doxycycline or other tetracyclines. Avoid sun exposure during treatment. Not generally recommended for children under 8 or during pregnancy. Tell your doctor about all medications you take, especially antacids, iron supplements, and blood thinners.
Before starting treatment with Doxycyklin EQL Pharma, it is essential to discuss your complete medical history with your healthcare provider. Several conditions and circumstances can affect whether doxycycline is the right choice for you, and your doctor needs to be aware of all relevant factors to ensure safe and effective treatment.
Contraindications
You must not take Doxycyklin EQL Pharma if you have a known hypersensitivity (allergy) to doxycycline, to any other tetracycline antibiotics, or to any of the inactive ingredients in the tablet. Tetracycline allergies, while relatively uncommon, can manifest as skin rashes, urticaria (hives), or in severe cases, anaphylaxis. If you have previously experienced an allergic reaction to any tetracycline antibiotic (such as tetracycline, minocycline, or oxytetracycline), you should not take doxycycline.
Warnings and Precautions
Speak with your doctor before taking Doxycyklin EQL Pharma in the following situations:
- Achlorhydria (absence of stomach acid): If you have a condition where your stomach does not produce hydrochloric acid, inform your doctor as this can affect drug absorption and may require monitoring
- Prolonged or troublesome diarrhea: If you develop persistent or severe diarrhea during treatment, contact your doctor immediately. This could indicate Clostridioides difficile-associated diarrhea, a potentially serious complication of antibiotic therapy that requires specific treatment
- Myasthenia gravis: If you have this neuromuscular condition that causes muscle weakness, inform your doctor. Tetracyclines may exacerbate muscle weakness in patients with myasthenia gravis
Serious skin reactions including Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS syndrome) and erythema multiforme have been reported with doxycycline. Stop taking the medication and seek immediate medical attention if you develop a widespread rash accompanied by high body temperature and enlarged lymph nodes, or if you experience rapidly developing skin rashes, fever, breathing difficulties, and/or facial swelling.
Photosensitivity – Sun Protection Is Essential
One of the most important precautions during doxycycline treatment is avoiding sun exposure. Doxycycline can cause photosensitivity reactions, making your skin significantly more sensitive to ultraviolet (UV) radiation. This applies to both natural sunlight and artificial UV sources such as tanning beds and sunlamps. The photosensitivity can result in an exaggerated sunburn response, with severe redness, blistering, and skin damage occurring even with brief sun exposure.
You should avoid prolonged sun exposure, use a broad-spectrum sunscreen with SPF 30 or higher, and wear protective clothing (long sleeves, hat, sunglasses) throughout the duration of treatment and for at least 5 days after completing your course. If you notice any unusual skin reaction to sunlight, contact your healthcare provider.
Children Under 8 Years
Children under 8 years of age should only be treated with Doxycyklin EQL Pharma on specific medical advice. Tetracycline antibiotics can cause permanent discoloration of developing teeth (yellow-grey-brown staining) and can be deposited in growing bone tissue, potentially affecting skeletal development. These effects occur because tetracyclines bind to calcium in developing teeth and bones. The risk is greatest during the second and third trimesters of pregnancy and in children up to 8 years of age. In some clinical situations, such as Rocky Mountain spotted fever or severe tick-borne illness, the benefits may outweigh the risks even in younger children.
Pregnancy and Breastfeeding
Doxycycline should not be used during pregnancy except on specific medical advice from a physician. There is a risk of harm to the developing fetus, including permanent tooth discoloration and effects on bone development. These risks are greatest during the second and third trimesters when teeth and bones are actively mineralizing.
Doxycycline does pass into breast milk but is unlikely to affect the nursing infant at therapeutic doses, partly because the calcium in breast milk forms insoluble chelates with doxycycline, reducing its bioavailability. However, you should always consult your healthcare provider before taking any medication while breastfeeding.
Driving and Operating Machinery
Doxycyklin EQL Pharma is not known to affect your ability to drive or operate machinery. No dose adjustment or special precautions are needed in this regard.
Lactose Content
Doxycyklin EQL Pharma tablets contain lactose monohydrate as an inactive ingredient. If you have been told by your doctor that you have an intolerance to certain sugars, contact your doctor before taking this medicine.
How Does Doxycyklin EQL Pharma Interact with Other Drugs?
Doxycycline interacts with antacids, iron supplements, calcium, and several other medications. Some drugs reduce doxycycline’s effectiveness while doxycycline may increase the effect of anticoagulants (blood thinners). Alcohol may also affect its efficacy. Always tell your doctor about all medications you take.
Drug interactions are an important consideration with doxycycline therapy. Several commonly used medications can significantly reduce the absorption or effectiveness of doxycycline, while doxycycline itself can alter the effects of other drugs. Understanding these interactions is crucial for ensuring that your antibiotic treatment is as effective as possible and that your other medications continue to work properly.
Major Interactions – Avoid Concurrent Use
The following medications should be avoided during treatment with Doxycyklin EQL Pharma due to significant interactions that can impair absorption or efficacy:
| Medication | Type | Effect on Doxycycline | Recommendation |
|---|---|---|---|
| Antacids (aluminum, magnesium) | Acid reflux treatment | Forms insoluble complexes, severely reduces absorption | Avoid; if necessary, take 2–3 hours apart |
| Iron supplements | Mineral supplement | Chelation reduces absorption of both drugs | Avoid; take at least 2–3 hours apart |
| Quinapril | ACE inhibitor (hypertension) | Contains magnesium that reduces absorption | Avoid concurrent use |
| Didanosine | Antiviral (HIV) | Buffered formulations reduce absorption | Avoid concurrent use |
| Atovaquone | Antimalarial / anti-Pneumocystis | Reduced atovaquone plasma levels | Avoid concurrent use |
Medications That Reduce Doxycycline’s Effectiveness
Several medications can reduce the effectiveness of doxycycline when taken concurrently. If you are taking any of the following, discuss timing and potential alternatives with your healthcare provider:
| Medication | Used For | How It Affects Doxycycline | What to Do |
|---|---|---|---|
| Calcium supplements | Bone health | Chelation reduces absorption | Take at least 3 hours before or after doxycycline |
| Rifampicin | Tuberculosis | Induces liver enzymes, accelerates metabolism | Doctor may increase dose or choose alternative |
| Phenobarbital, Phenytoin, Carbamazepine | Epilepsy | Induce hepatic enzymes, reduce doxycycline half-life | Doctor may adjust dose; monitoring recommended |
| Proton pump inhibitors (omeprazole, pantoprazole, lansoprazole, rabeprazole, esomeprazole) | Acid reflux, ulcers | Reduce stomach acid production, may decrease absorption | Inform your doctor; monitoring may be needed |
Doxycycline’s Effect on Other Medications
Doxycycline can also affect the way other medications work in your body. Of particular clinical importance is its interaction with anticoagulants (blood-thinning medications such as warfarin). Doxycycline can enhance the anticoagulant effect, potentially increasing the risk of bleeding. If you are on long-term anticoagulant therapy, your doctor may need to reduce your anticoagulant dose during doxycycline treatment and monitor your INR (International Normalized Ratio) more frequently.
Food and Alcohol
Unlike many other tetracyclines, doxycycline absorption is only minimally affected by food, milk, and dairy products. In fact, taking doxycycline with food is recommended to reduce gastrointestinal side effects. However, the effect of doxycycline may be reduced by concurrent alcohol consumption. Chronic alcohol use can increase the hepatic metabolism of doxycycline, potentially reducing its therapeutic levels. It is advisable to limit alcohol intake during treatment.
What Is the Correct Dosage of Doxycyklin EQL Pharma?
For adults and children over 12 years: 200 mg (2 tablets) on the first day, then 100 mg (1 tablet) once daily. Swallow with a full glass of water with food. Do not lie down after taking. The scored tablet can be halved if needed for swallowing.
Always take Doxycyklin EQL Pharma exactly as your doctor has prescribed. Do not change the dose or stop treatment without consulting your healthcare provider. The dosage and duration of treatment depend on the type and severity of infection being treated.
Adults and Children Over 12 Years
Standard Dosing Regimen
Day 1 (loading dose): 200 mg (2 tablets) – this higher initial dose rapidly achieves therapeutic blood levels
Day 2 onwards (maintenance dose): 100 mg (1 tablet) once daily
Because doxycycline is eliminated slowly from the body (half-life of 16–22 hours), once-daily dosing is sufficient in most clinical situations. This is a significant advantage over older tetracyclines that require multiple daily doses.
How to Take the Tablets
- Swallow with a full glass of liquid (water is preferred) to ensure the tablet reaches the stomach and does not lodge in the esophagus
- Take with food to reduce gastrointestinal discomfort such as nausea
- Do not lie down for at least 30 minutes after taking the tablet to prevent esophageal irritation and ulceration
- The scored tablet can be halved if you have difficulty swallowing it whole; the score line is provided solely for this purpose, not for dose splitting
Children Under 12 Years
Doxycycline is generally not recommended for children under 8 years due to the risk of permanent tooth discoloration and effects on bone development. For children aged 8–12 years, dosing is typically based on body weight and should only be prescribed by a physician who has carefully weighed the benefits against the risks. The usual pediatric dose is 4 mg/kg on the first day, followed by 2 mg/kg daily thereafter.
Elderly Patients
No specific dose adjustment is generally required for elderly patients with normal renal and hepatic function. However, elderly individuals may be more susceptible to certain side effects, particularly esophageal irritation and photosensitivity. Standard precautions regarding taking tablets with food and adequate fluids are especially important in this population.
Missed Dose
If you forget to take a dose of Doxycyklin EQL Pharma, take it as soon as you remember, unless it is almost time for your next scheduled dose. Do not take a double dose to make up for a missed one. Taking two doses at once increases the risk of side effects without improving treatment efficacy. If you are unsure about what to do, contact your pharmacist or doctor for advice.
Overdose
If you have taken more than the prescribed amount of Doxycyklin EQL Pharma, or if a child has accidentally ingested the medication, contact your healthcare provider, go to the nearest emergency department, or call your local poison control center immediately. Symptoms of overdose may include severe nausea, vomiting, and diarrhea. Treatment is symptomatic and supportive.
Even if your symptoms improve or disappear after just a few days of treatment, it is critically important to continue taking Doxycyklin EQL Pharma for the full duration prescribed by your doctor. Stopping antibiotics early can allow bacteria to survive and develop resistance, making future infections harder to treat. Incomplete courses also increase the risk of the infection returning.
What Are the Side Effects of Doxycyklin EQL Pharma?
Common side effects include nausea, vomiting, and diarrhea, which can be reduced by taking the medication with food. Uncommon effects include skin rash and photosensitivity. Rare but serious reactions include DRESS syndrome and severe allergic reactions requiring immediate medical attention.
Like all medicines, Doxycyklin EQL Pharma can cause side effects, although not everybody gets them. Most side effects are mild and resolve after stopping treatment. However, some reactions can be serious and require immediate medical attention. Understanding what to watch for helps you respond appropriately if side effects occur.
- Widespread rash, high body temperature, and enlarged lymph nodes (DRESS syndrome)
- Rapidly developing skin rashes, fever, breathing difficulties, and/or facial swelling (severe allergic reaction)
Jarisch-Herxheimer Reaction
When doxycycline is used to treat infections caused by spirochetal bacteria, such as Lyme disease (borreliosis), a Jarisch-Herxheimer reaction may occur shortly after starting treatment. This reaction causes fever, chills, headache, muscle pain, and skin rash. It is caused by the release of bacterial toxins as the bacteria are killed and is usually self-limiting, resolving within 24 hours. Contact your doctor promptly if you experience these symptoms.
Side Effect Frequency
Common
Affects more than 1 in 100 people
- Nausea
- Vomiting
- Diarrhea
Uncommon
Affects fewer than 1 in 100 people
- Skin rash and urticaria (hives)
- Photosensitivity (increased sensitivity to sunlight)
Rare
Affects fewer than 1 in 1,000 people
- Hypersensitivity (allergic) reactions
- Thrombocytopenia (decreased blood platelets)
- Onycholysis (nail detachment)
- Skin redness (erythema)
- Mucosal and skin inflammation of varying severity
- Raised intracranial pressure (symptoms: headache, reduced vision)
- Colitis (inflammation of the large intestine)
Not Known
Frequency cannot be estimated from available data
- Esophagitis (inflammation of the esophagus)
- Esophageal ulceration
- Oral or vaginal thrush (candidiasis) due to disruption of normal bacterial flora
Gastrointestinal Side Effects
Nausea, vomiting, and diarrhea are the most commonly reported side effects of doxycycline. These gastrointestinal effects occur because antibiotics affect not only the disease-causing bacteria but also the beneficial bacteria that normally inhabit the digestive tract. Taking doxycycline with food can significantly reduce these side effects without meaningfully affecting drug absorption – a notable advantage of doxycycline over other tetracyclines.
If diarrhea is severe, persistent, or contains blood, contact your healthcare provider promptly, as this may indicate Clostridioides difficile infection, which requires specific treatment.
Esophageal Irritation
Doxycycline tablets can cause irritation, inflammation, and even ulceration of the esophagus if they become lodged in the esophagus. This is why it is essential to swallow the tablets with a full glass of water and to remain upright (sitting or standing) for at least 30 minutes after taking the medication. Taking tablets at bedtime or just before lying down significantly increases this risk.
Fungal Overgrowth
By disrupting the normal bacterial flora, doxycycline can sometimes allow fungal organisms (particularly Candida species) to overgrow, resulting in oral thrush (white patches in the mouth) or vaginal thrush (vaginal candidiasis with itching and discharge). If these symptoms develop and persist, consult your healthcare provider, as antifungal treatment may be needed.
It is important to report suspected side effects after a medicine has been authorized. This makes it possible to continuously monitor the benefit-risk balance of the medicine. Healthcare professionals and patients can report suspected adverse reactions to their national medicines regulatory authority.
How Should You Store Doxycyklin EQL Pharma?
Store Doxycyklin EQL Pharma out of sight and reach of children. No special storage conditions are required. Do not use after the expiry date printed on the packaging. Never dispose of medicines through household waste or water drainage.
Proper storage of medications is essential to maintain their efficacy and safety throughout the product’s shelf life. Doxycyklin EQL Pharma should be stored following these guidelines:
- Keep out of the sight and reach of children – store in a location that is not accessible to children. Accidental ingestion by children can cause tooth discoloration and other adverse effects
- No special storage conditions – unlike some medications, Doxycyklin EQL Pharma does not require refrigeration or specific temperature conditions. Store at room temperature in the original packaging
- Check the expiry date – do not use after the expiry date stated on the carton. The expiry date refers to the last day of the stated month. Expired tetracycline antibiotics should never be used, as degradation products can potentially cause kidney damage (a condition historically known as Fanconi syndrome)
- Disposal – medicines should not be disposed of via household waste or wastewater. Return unused medicines to your pharmacy for proper disposal. These measures help protect the environment from pharmaceutical contamination
What Does Doxycyklin EQL Pharma Contain?
Each tablet contains doxycycline monohydrate equivalent to 100 mg doxycycline as the active substance. Inactive ingredients include microcrystalline cellulose, sodium starch glycolate, hypromellose, lactose monohydrate, talc, magnesium stearate, and colloidal silicon dioxide.
Active Substance
The active substance is doxycycline monohydrate, equivalent to 100 mg doxycycline per tablet. The monohydrate salt form provides excellent stability and bioavailability.
Inactive Ingredients (Excipients)
The other ingredients are:
- Microcrystalline cellulose – a plant-derived filler and binder that provides structural integrity to the tablet
- Sodium starch glycolate – a disintegrant that helps the tablet break down quickly in the stomach for efficient absorption
- Hypromellose – a cellulose derivative used as a binder and film-forming agent
- Lactose monohydrate – a sugar filler (important for patients with lactose intolerance)
- Talc – an anti-caking and lubricating agent
- Magnesium stearate – a lubricant that prevents the tablet from sticking to manufacturing equipment
- Colloidal silicon dioxide – a flow agent that ensures uniform tablet composition
Appearance and Pack Sizes
Doxycyklin EQL Pharma 100 mg tablets are greyish-yellow, round, and convex with a score line. The score line is intended only to facilitate breaking the tablet for ease of swallowing and not for dividing it into equal doses. The tablets are supplied in blister packs of 10 or 15 tablets, with available pack sizes of 10, 15, 20, 30, and 100 tablets. Not all pack sizes may be marketed in every country.
Frequently Asked Questions About Doxycyklin EQL Pharma
Doxycycline is a second-generation tetracycline with several advantages over older tetracyclines like tetracycline and oxytetracycline. It has a longer half-life (16–22 hours versus 6–8 hours), allowing once-daily dosing instead of multiple daily doses. Its absorption is minimally affected by food and dairy products, unlike older tetracyclines whose absorption is significantly reduced by calcium-containing foods. Doxycycline also has superior tissue penetration and a broader spectrum of activity, including excellent coverage against atypical respiratory pathogens.
Yes, unlike older tetracyclines, doxycycline absorption is only minimally affected by milk and dairy products. You can take doxycycline with food, including dairy-containing meals, without significantly reducing its effectiveness. In fact, taking it with food is recommended to reduce potential stomach discomfort. However, calcium supplements in high doses should still be taken at least 3 hours apart from doxycycline.
Doxycycline reaches peak blood levels within 2–3 hours after oral administration. The loading dose of 200 mg on the first day is designed to achieve therapeutic levels rapidly. Most patients begin to feel improvement within 24–48 hours of starting treatment, but this varies depending on the type and severity of infection. It is essential to complete the full course of treatment even if you feel better after a few days, as stopping early can lead to treatment failure and antibiotic resistance.
If you develop a sunburn or photosensitivity reaction while taking doxycycline, move out of the sun immediately and apply cool compresses to affected areas. Use a soothing moisturizer or aloe vera gel, and take over-the-counter pain relief if needed. Contact your healthcare provider, especially if the reaction is severe (blistering, extensive redness, or swelling). Your doctor may consider switching to an alternative antibiotic if the photosensitivity is severe. Continue to protect your skin from sun exposure for the remainder of treatment and for at least 5 days after stopping.
Most blood pressure medications can be taken safely with doxycycline. However, quinapril (an ACE inhibitor) contains magnesium that can significantly reduce doxycycline absorption, and concurrent use should be avoided. Other ACE inhibitors and blood pressure medications are generally compatible. Always inform your prescribing doctor about all medications you are taking, including antihypertensives, so they can assess potential interactions and advise on optimal timing of doses if needed.
No. Doxycycline is an antibiotic that only works against bacterial infections. It has no effect on viral infections such as the common cold, influenza (flu), COVID-19, or other viral illnesses. Taking antibiotics for viral infections is not only ineffective but contributes to antibiotic resistance, a growing global health threat identified by the WHO. Your healthcare provider will determine whether your infection is bacterial and requires antibiotic treatment.
References
This article is based on the following evidence-based medical sources:
- World Health Organization (WHO). Model List of Essential Medicines, 23rd List, 2023. Geneva: WHO. Doxycycline listed as an essential antibiotic.
- European Medicines Agency (EMA). Summary of Product Characteristics: Doxycycline. EMA/CHMP guidelines on tetracycline antibiotics.
- U.S. Food and Drug Administration (FDA). Doxycycline Prescribing Information. FDA-approved labeling for doxycycline hyclate and monohydrate formulations.
- British National Formulary (BNF). Doxycycline Monograph. National Institute for Health and Care Excellence (NICE), 2024.
- Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232-260. doi:10.1128/MMBR.65.2.232-260.2001
- Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-1134.
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
- Holmes NE, Charles PG. Safety and efficacy review of doxycycline. Clin Med Ther. 2009;1:471-482.
About Our Medical Editorial Team
This article has been written, reviewed, and fact-checked by qualified healthcare professionals with expertise in pharmacology and infectious disease medicine. Our editorial process follows international standards for medical content.
Medical Writing & Research
Content created by medical writers with backgrounds in pharmacology, clinical medicine, and evidence-based healthcare communication. All clinical claims verified against current guidelines (WHO, EMA, FDA, BNF).
Medical Review Board
Reviewed by board-certified physicians specializing in infectious disease and clinical pharmacology. Following GRADE evidence framework and international prescribing guidelines.
Last medical review: | Next scheduled review: